News

In light of controversy over the recent semaglutide drug shortages for the diabetes patients they're indicated for, one doctor illuminates another side of the case. From the Kardashians to that person ...
The SOUL trial compared oral semaglutide vs. placebo on top of standard care in patients with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease or both.
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...
Home remedies such as lozenges and honey may help. It is often possible to manage an itchy throat at home. However, if itchiness persists or keeps coming back, it is best to contact a doctor for ...
It is possible to take ginger as a tea, juice, or lozenge. People can also add ginger to smoothies or meals. Combining ginger with honey and other anti-inflammatory ingredients is a popular way of ...
Oral semaglutide 14 mg was associated with better cardiometabolic outcomes than active comparators, including empaglifozin and liraglutide, among patients with T2D. Oral semaglutide improves ...
This comprehensive review explores MEDVi, a leading telehealth provider offering compounded GLP-1 weight loss solutions like Semaglutide and Tirzepatide in both injection and tablet form.
Ozempic is the brand name for semaglutide, which is the active ingredient in several weight loss medications. Semaglutide is known as a 'GLP-1 receptor agonist' which is a drug that imitates your ...
For the study, researchers followed 262 adults who were prescribed GLP-1 medications like semaglutide or liraglutide to help with weight loss. The researchers also tracked changes in alcohol use ...
Semaglutide is available for private prescription ... dry mouth can also be treated with saliva substitutes, such as lozenges, gums or sprays. “Avoid acidic, sugary foods or overly processed ...
Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review the ...